Fusion Pharmaceuticals
infiltration of antigen specific cells is responsible for vaccine effect tumor i | Fusion Pharmaceuticals
Deck Type
IPO
Deck date
June 2020
Slide
33 of 49
Related slides by other companies
Investor Day
November 2022
Investor Presentation
January 2024
Other recent decks by Fusion Pharmaceuticals
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies